SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-20-003785
Filing Date
2020-02-21
Accepted
2020-02-21 16:39:30
Documents
84
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10k.htm 10-K 1202291
2 EXHIBIT 4.9 ex4_9.htm EX-4.9 21229
3 EXHIBIT 23.1 ex23_1.htm EX-23.1 2623
4 EXHIBIT 24.1 ex24_1.htm EX-24.1 15699
5 EXHIBIT 31.1 ex31_1.htm EX-31.1 12654
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 6728
  Complete submission text file 0001140361-20-003785.txt   6395556

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rexn-20191231.xml EX-101.INS 1495387
8 XBRL TAXONOMY EXTENSION SCHEMA rexn-20191231.xsd EX-101.SCH 56675
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rexn-20191231_cal.xml EX-101.CAL 48154
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rexn-20191231_def.xml EX-101.DEF 189868
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rexn-20191231_lab.xml EX-101.LAB 416274
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rexn-20191231_pre.xml EX-101.PRE 364633
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34079 | Film No.: 20640642
SIC: 2834 Pharmaceutical Preparations